Biotech

All Articles

Oncternal stock sinks 60% among cutbacks, trial discontinuations

.Cancer firm Oncternal Therapeutics is folding all its own professional tests and also giving up sta...

Roche is carrying out chances that its own injectable weight problems prospect could ultimately show 25% weight management in late-stage trial

.Roche is actually holding out chances that its own injectable weight problems prospect might ultima...

Novo Nordisk barrages 'impressive' weight loss lead for dual-acting oral drug in early trial

.Novo Nordisk has actually lifted the lid on a stage 1 trial of its oral amylin and GLP-1 receptor c...

AbbVie sues BeiGene over blood stream cancer cells drug proprietary knowledge

.Just a couple of brief full weeks after succeeding an FDA Fast lane tag for its own investigational...

Lilly provides one-two blow with second tranche of beneficial records on every week blood insulin applicant

.Soon after a beneficial information reduce for Eli Lilly's efsitora alfa, the Indianapolis-based co...

BridgeBio cuts gene treatment budget as scientific records disappoint

.BridgeBio Pharma is actually lowering its gene treatment spending plan as well as pulling back from...

GSK relinquishes HSV vaccine wishes after phase 2 neglect, transferring race to Moderna, BioNTech

.GSK's attempt to develop the very first vaccine for herpes simplex virus (HSV) has actually finishe...

GSK's long-acting breathing problem medicine halved strikes in phase 3

.GSK's long-acting bronchial asthma therapy has actually been shown to cut in half the amount of str...

AstraZeneca, Daiichi unbox Dato-DXd's overall survival fail

.AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has actually fallen s...

Roivant reveals new 'vant' to accelerate Bayer hypertension med

.Matt Gline is back along with a brand new 'vant' company, after the Roivant Sciences chief executiv...